EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Efficacy of Intravenous Methylprednisolone Pulses in Children With Postinfectious Bronchiolitis Obliterans

Souad Ghattas, David Drummond iD, Alice Hadchouel iD

Pediatric Pulmonology · 2025

DOI: 10.1002/ppul.71150 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Pulmonology, 2025. Verfasst von Souad Ghattas und 2 weiteren Autor:innen. Beteiligte Einrichtung: AP-HP, Hôpital Universitaire Necker-Enfants Malades, Service de Pneumologie Pédiatrique, Centre de Référence pour les Maladies Respiratoires Rares de…. Hauptthemen laut MEDLINE: Methylprednisolone, Bronchiolitis Obliterans, Glucocorticoids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To assess the efficacy of intravenous methylprednisolone pulses in children with postinfectious bronchiolitis obliterans (PIBO). Study Design/Methods This French monocentric retrospective study included 31 patients with PIBO. Respiratory symptoms, occurrence of exacerbations and hospitalizations up to 4 years, and the results of lung function tests were compared between patients who received methylprednisolone pulses ( n = 6) and those who did not ( n = 25). A similar analysis was performed in the subgroup of the severest patients at diagnosis (five and six patients per group respectively).

Results

During their inaugural episode, patients in the treatment group were hospitalized longer ( p = 0.005), more frequently in ICU ( p = 0.013) and had longer oxygen needs than in the control group ( p = 0.005). During their course, more patients in the treatment group required at least one nonscheduled hospitalization at 6 months of evolution than in the control group ( p = 0.04). Regarding lung function tests, no significant difference was observed between the control and treatments groups. Comparing the severest patients at diagnosis in each group showed no significant difference in clinical nor functional evolution.

Conclusion

In a retrospective monocentric cohort, intravenous methylprednisolone pulses were used in severe cases of PIBO. This treatment had no effect of the subsequent evolution of these patients as compared to not treated patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethylprednisoloneBronchiolitis ObliteransGlucocorticoidsHumansRetrospective StudiesMaleFemaleChild, PreschoolInfantTreatment OutcomeRespiratory Function TestsChildAdministration, IntravenousHospitalization

Stichwörter der Autor:innen

childrenchronic obstructive lung diseasesteroids

Substanzen

MethylprednisoloneGlucocorticoids

Autor:innen und Institutionen

  • AP-HP, Hôpital Universitaire Necker-Enfants Malades, Service de Pneumologie Pédiatrique, Centre de Référence pour les Maladies Respiratoires Rares de l'Enfant, Paris, France.
  • Université Paris Cité, Paris, France.
  • INSERM U1151, Institut Necker Enfants Malades-INEM, Paris, France.

ORCID-Profile: David Drummond, Alice Hadchouel

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Ghattas, S., Drummond, D., & Hadchouel, A. (2025). Efficacy of Intravenous Methylprednisolone Pulses in Children With Postinfectious Bronchiolitis Obliterans. Pediatric Pulmonology. https://doi.org/10.1002/ppul.71150

Vancouver

Ghattas S, Drummond D, Hadchouel A. Efficacy of Intravenous Methylprednisolone Pulses in Children With Postinfectious Bronchiolitis Obliterans. Pediatric Pulmonology. 2025. doi:10.1002/ppul.71150

BibTeX
@article{Ghattas2025,
  author = {Ghattas, Souad and Drummond, David and Hadchouel, Alice},
  title = {Efficacy of Intravenous Methylprednisolone Pulses in Children With Postinfectious Bronchiolitis Obliterans},
  journal = {Pediatric Pulmonology},
  year = {2025},
  doi = {10.1002/ppul.71150}
}
Kostenlos starten →